4B-MAR

4'-Bromo-4-methylaminorex
Identifiers
IUPAC name
  • 4-methyl-5-(4-bromophenyl)-4,5-dihydro-1,3-oxazol-2-amine
CAS Number
  • none
PubChem CID
Chemical and physical data
FormulaC10H11BrN2O
Molar mass255.115 g·mol−1
3D model (JSmol)
SMILES
  • CC1C(OC(=N1)N)C2=CC=C(C=C2)Br
InChI
  • InChI=1S/C10H11BrN2O/c1-6-9(14-10(12)13-6)7-2-4-8(11)5-3-7/h2-6,9H,1H3,(H2,12,13)
  • Key:TUHDNALAVIDYHT-UHFFFAOYSA-N

4'-Bromo-4-methylaminorex (4B-MAR, 4'-Br-4-MAR) is a designer drug from the substituted aminorex family, first definitively identified in Austria in January 2022. Its pharmacological activity has not been reported, but it is believed to have stimulant effects.[1]

See also

References

  1. ↑ Seibert E, Kunert O, Pferschy-Wenzig EM, Schmid MG (September 2022). "Characterization of Three Novel 4-Methylaminorex Derivatives Applied as Designer Drugs". Molecules. 27 (18). Basel, Switzerland: 5770. doi:10.3390/molecules27185770. PMC 9503756. PMID 36144500.


This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.